Regeneron Pharmaceuticals (REGN)
Cash & Equivalents
$2.46B
Quarterly · Period ending: · USD
REGN Cash & Equivalents
Latest reported$2.46Bperiod ending
Latest reported$2.46Bperiod ending
REGN Quarterly Cash & Equivalents ($21.80M → $2.46B)
Quarterly Cash & Equivalents
High-resolution chart · PNG
REGN cash & equivalents history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 142,955,000 | |
| 183,620,000 | |
| 30,978,000 | |
| 49,642,000 | |
| 81,751,000 | |
| 12,294,000 | |
| 23,700,000 | |
| 23,500,000 | |
| 20,600,000 | |
| 21,800,000 | |
| 19,800,000 | |
| 22,600,000 | |
| 22,500,000 | |
| 19,300,000 | |
| 28,900,000 | |
| 40,300,000 | |
| 51,400,000 | |
| 27,900,000 | |
| 34,500,000 | |
| 37,500,000 | |
| 48,900,000 | |
| 11,900,000 | |
| 32,700,000 | |
| 5,900,000 | |
| 16,800,000 | |
| 12,700,000 | |
| 23,600,000 | |
| 15,300,000 | |
| 18,000,000 | |
| 8,000,000 | |
| 12,500,000 | |
| 39,700,000 | |
| 7,900,000 | |
| 10,100,000 | |
| 16,400,000 | |
| 19,200,000 | |
| 22,000,000 | |
| 24,900,000 | |
| 26,200,000 | |
| 35,000,000 | |
| 39,200,000 | |
| 21,800,000 |